Horizon Europe: Health

Development of new effective therapies for rare diseases

Frist: 1. Februar 2022

Less than 6% of rare diseases have an approved treatment option. By approaching rare diseases with commonalities like shared biological features proposals should address multiple rare diseases and not a single disease.

Proposals for this call should contribute to at least one of the following outcomes:

  • Researchers make better use of new knowledge
  • Researchers use robust preclinical technologies to increase the successful development of new therapies for rare diseases.
  • Regulators can approve therapies for rare diseases faster due to more successful late-stage interventions tested.
  • People living with rare disease get access to new therapies or medical products

Call ID: HORIZON-HLTH-2022-DISEASE-06-04-two-stage

Förderung von Projekten innerhalb:

Offizieller Aufruf von Horizon Europe: Health

Kontaktanfrage zur Finanzierung durch Horizon Europe: Health

Lassen Sie uns ein unverbindliches Gespräch führen über Ihre Möglichkeiten, die Unterstützung durch Horizon Europe: Health zu erwerben.

Über Horizon Europe: Health

The Horizon Europe: Health Cluster supports research and innovation that contribute to Europe’s recovery and resilience from the global pandemic as well as projects aimed at the cancer care pathway. There are six specific areas of impact contained in the Health Cluster:

  • Staying healthy in a rapidly changing society
  • Living and working in a health-promoting environment
  • Tackling diseases and reducing disease burden
  • Ensuring access to innovative, sustainable and high-quality health care
  • Unlocking the full potential of new tools, technologies and digital solutions for a healthy society
  • Maintaining an innovative, sustainable and globally competitive health-related industry
Mehr über diesen Zuschüss